Antibiotics-Basel

Scope & Guideline

Exploring the frontiers of biochemistry and pharmacology in antibiotics.

Introduction

Explore the comprehensive scope of Antibiotics-Basel through our detailed guidelines, including its aims and scope. Stay updated with trending and emerging topics, and delve into declining areas to understand shifts in academic interest. Our guidelines also showcase highly cited topics, featuring influential research making a significant impact. Additionally, discover the latest published papers and those with high citation counts, offering a snapshot of current scholarly conversations. Use these guidelines to explore Antibiotics-Basel in depth and align your research initiatives with current academic trends.
LanguageEnglish
ISSN2079-6382
PublisherMDPI
Support Open AccessYes
CountrySwitzerland
TypeJournal
Converge2010, from 2012 to 2024
AbbreviationANTIBIOTICS-BASEL / Antibiotics-Basel
Frequency12 issues/year
Time To First Decision-
Time To Acceptance-
Acceptance Rate-
Home Page-
AddressST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND

Aims and Scopes

The journal 'Antibiotics-Basel' focuses on the multifaceted field of antibiotic research, encompassing various aspects of antimicrobial resistance, novel therapies, and the implications of antibiotic use across different settings. The journal aims to provide a comprehensive platform for researchers to share innovative findings that contribute to understanding and combating antibiotic resistance, improving patient outcomes, and enhancing public health.
  1. Antimicrobial Resistance Mechanisms:
    Research on the genetic, biochemical, and environmental factors contributing to the emergence and spread of antimicrobial resistance genes in various microbial populations.
  2. Novel Antimicrobial Agents:
    Development and evaluation of new antibiotics, including synthetic compounds, natural products, and their mechanisms of action against resistant pathogens.
  3. Antibiotic Stewardship Practices:
    Studies evaluating the effectiveness of antimicrobial stewardship programs in hospitals and community settings to optimize antibiotic use and reduce resistance.
  4. Clinical Outcomes and Pharmacokinetics:
    Research on the pharmacokinetics and pharmacodynamics of antibiotics, including dosing strategies and their impact on clinical outcomes in various populations.
  5. Environmental Impact of Antibiotics:
    Exploration of antibiotic residues in the environment and their role in selecting for resistant strains, including studies on wastewater treatment and agricultural runoff.
  6. One Health Approach to Antibiotic Use:
    Interdisciplinary research that addresses antibiotic resistance across human, animal, and environmental health sectors, emphasizing the interconnectedness of these fields.
The journal 'Antibiotics-Basel' is witnessing significant growth in specific research areas, reflecting current challenges and advancements in the field of antimicrobial resistance and therapy. The following emerging themes highlight the latest trends and priorities in antibiotic research.
  1. Phage Therapy and Alternative Treatments:
    An increasing number of studies are exploring bacteriophage therapy as a viable alternative to traditional antibiotics, especially for multi-drug-resistant infections.
  2. Environmental Antibiotic Resistance Studies:
    There is a growing focus on understanding the environmental factors contributing to the spread of antibiotic resistance, including studies on wastewater treatment and agricultural practices.
  3. Machine Learning and AI in Antibiotic Research:
    The integration of artificial intelligence and machine learning techniques to predict antibiotic resistance patterns and optimize treatment protocols is emerging as a significant trend.
  4. Antimicrobial Peptides (AMPs):
    Research into the development and application of antimicrobial peptides as novel therapeutic agents against resistant pathogens is gaining momentum.
  5. Impact of Antibiotic Stewardship on Clinical Outcomes:
    There is an increasing emphasis on evaluating the real-world impact of antimicrobial stewardship programs on patient outcomes and healthcare costs.
  6. Resistance Mechanisms in Emerging Pathogens:
    A trend towards investigating resistance mechanisms in new and emerging pathogens, particularly in the context of zoonotic diseases and public health implications.

Declining or Waning

While 'Antibiotics-Basel' has a broad and evolving scope, certain themes appear to be declining in prominence based on recent publication trends. This section highlights these waning areas of focus, which may reflect shifts in research priorities or emerging challenges in the field.
  1. Traditional Antibiotic Usage Studies:
    There has been a noticeable decrease in studies solely focused on traditional antibiotic usage patterns without integrating newer approaches or technologies.
  2. Single-Agent Antibiotic Efficacy Studies:
    Research focusing exclusively on the efficacy of single antibiotics is waning as there is a growing emphasis on combination therapies and multi-drug approaches to combat resistance.
  3. Basic Research on Antibiotic Mechanisms:
    While still relevant, the focus on purely mechanistic studies of antibiotics is declining in favor of translational research that bridges laboratory findings with clinical applications.
  4. Antibiotic Resistance in Non-Clinical Settings:
    There is a noticeable decrease in studies addressing antibiotic resistance in non-clinical environments, such as community settings outside hospitals, as the focus shifts towards clinical implications and hospital-acquired infections.

Similar Journals

JOURNAL OF CHEMOTHERAPY

Empowering Innovations in Oncology and Pharmacology
Publisher: TAYLOR & FRANCIS LTDISSN: 1120-009XFrequency: 6 issues/year

Journal of Chemotherapy is a distinguished peer-reviewed academic journal published by Taylor & Francis Ltd, focusing on the dynamic fields of infectious diseases, oncology, and pharmacology. With its ISSN 1120-009X and E-ISSN 1973-9478, this journal has been at the forefront of chemotherapy research since its inception in 1989 and continues to play a vital role in advancing medical science through rigorous studies and reviews. It currently holds a respectable position in various Scopus categories, ranked Q3 in several important disciplines, reflecting its commitment to providing quality research. Although it operates under a subscription model, Journal of Chemotherapy remains a crucial resource for practitioners and academics alike, facilitating knowledge exchange and innovation in the treatment of diseases through chemotherapy. With access to the latest findings and therapeutic advancements, this journal is a must-read for researchers, medical professionals, and students seeking to enhance their understanding of emerging trends in chemotherapy.

International Journal of Microbiology

Connecting Researchers Across Borders in Microbiology
Publisher: HINDAWI LTDISSN: 1687-918XFrequency: 1 issue/year

Welcome to the International Journal of Microbiology, a premier platform dedicated to the dissemination of cutting-edge research in the field of microbiology. Published by HINDAWI LTD, this open-access journal has been making significant strides since its inception in 2009, ensuring that high-quality research is accessible to all. Situated in Egypt, the journal caters to an international audience, fostering collaboration across borders. With a commendable impact factor and recognized in the Q2 category for both general and medical microbiology, it ranks 48th out of 182 and 40th out of 140, respectively, according to Scopus statistics, placing it among the top-tier journals in its field. The International Journal of Microbiology publishes articles that explore various aspects of microbiology, from fundamental studies to applied research, thus contributing significantly to advancements in medical, agricultural, and environmental microbiology. This journal is an essential resource for researchers, professionals, and students eager to stay at the forefront of microbiological studies and their applications.

Journal of Pediatric Infection

Empowering knowledge for healthier futures.
Publisher: AVES YAYINCILIK, IBRAHIM KARAISSN: 1307-1068Frequency: 4 issues/year

Journal of Pediatric Infection is a vital academic resource dedicated to the ever-evolving field of infectious diseases in pediatric populations. Published by AVES YAYINCILIK in Turkey, this journal features a rigorous peer-review process and has established itself as a platform for innovative research from around the globe. Although currently categorized in the Q4 quartile for both Infectious Diseases and Pediatrics, Perinatology and Child Health, the journal's potential for growth is substantial, attracting contributions that aim to shed light on the complexities of infectious diseases affecting children. With a converged publication history from 2009 to 2024, the journal emphasizes the importance of advancing knowledge in pediatric health through systematic reviews, original research, and case studies. Its open access policy encourages unrestricted sharing of vital research findings, making it an essential read for researchers, clinicians, and students dedicated to improving pediatric healthcare outcomes.

ANTONIE VAN LEEUWENHOEK INTERNATIONAL JOURNAL OF GENERAL AND MOLECULAR MICROBIOLOGY

Exploring the Depths of Molecular Microbiology
Publisher: SPRINGERISSN: 0003-6072Frequency: 12 issues/year

ANTONIE VAN LEEUWENHOEK INTERNATIONAL JOURNAL OF GENERAL AND MOLECULAR MICROBIOLOGY, published by Springer, is a vital resource for advancing research in the fields of microbiology and molecular biology. With its ISSN 0003-6072 and E-ISSN 1572-9699, this journal consistently focuses on cutting-edge studies and developments, providing a platform for the dissemination of knowledge that spans over its rich history from 1934 onwards. The journal holds an impressive reputation, ranked Q2 in Medicine (miscellaneous) and Q3 in both Microbiology and Molecular Biology for 2023, reflecting its significant contribution to the scientific community. Researchers and professionals from various disciplines rely on this journal for quality publications that address complex microbial interactions and molecular mechanisms. Although it currently does not provide open access options, its compelling research remains accessible through institutional subscriptions, allowing it to foster collaborative advancements in the ever-evolving landscape of microbiological sciences.

MIKROBIYOLOJI BULTENI

Shaping the Future of Microbial Science
Publisher: ANKARA MICROBIOLOGY SOCISSN: 0374-9096Frequency: 4 issues/year

MIKROBIYOLOJI BULTENI, with ISSN 0374-9096, is a prestigious academic journal published by the ANKARA MICROBIOLOGY SOC, located in Ankara, Turkey. Established in 1973, this journal has been a vital conduit for disseminating research in the fields of Immunology, Microbiology, and Infectious Diseases, garnering a reputation as a significant contributor to the scientific community. The journal is currently ranked in the Q3 category within Immunology and Microbiology (miscellaneous), and Infectious Diseases, indicating its impactful presence amidst contemporary research. With access options that may be restricted, MIKROBIYOLOJI BULTENI actively welcomes submissions that advance the understanding of critical microbiological principles and practices, thereby supporting both national and international research efforts. Researchers, professionals, and students are encouraged to explore the latest findings shared in this journal, as it continually shapes the landscape of microbiology and infectious disease studies through its comprehensive and rigorous peer-reviewed publications.

INFECTIOUS DISEASES IN CLINICAL PRACTICE

Connecting academia and healthcare for impactful solutions.
Publisher: LIPPINCOTT WILLIAMS & WILKINSISSN: 1056-9103Frequency: 6 issues/year

INFECTIOUS DISEASES IN CLINICAL PRACTICE, published by Lippincott Williams & Wilkins, is a crucial resource in the field of infectious diseases and microbiology. With an ISSN of 1056-9103 and an E-ISSN of 1536-9943, this journal has been a platform for scholarly communication since its inception in 1992, now spanning over two decades of continuous publication. The journal primarily focuses on the latest research developments, case studies, and clinical practices relevant to infectious diseases, making it an indispensable tool for researchers, healthcare professionals, and students alike. Although it is currently categorized in the Q4 quartile for both Infectious Diseases and Medical Microbiology, it continues to strive for excellence and relevance in a rapidly evolving field. By facilitating open access to impactful articles (note: Open Access not applicable), the journal aims to enhance global understanding and management of infectious diseases, ensuring that practitioners are well-equipped to confront contemporary challenges in this critical area of public health. Situated in the United States at TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103, INFECTIOUS DISEASES IN CLINICAL PRACTICE plays an essential role in fostering academic discourse and advancing clinical knowledge.

JOURNAL OF MICROBIOLOGY

Leading the charge in microbiological research and innovation.
Publisher: MICROBIOLOGICAL SOCIETY KOREAISSN: 1225-8873Frequency: 12 issues/year

JOURNAL OF MICROBIOLOGY, published by the Microbiological Society Korea, is a prestigious peer-reviewed journal dedicated to the advancement of knowledge in the fields of microbiology, applied microbiology, and biotechnology. Established in 1996, this journal serves as a vital platform for researchers and professionals from around the globe to disseminate their findings and engage in multidisciplinary discussions pertaining to microbial sciences. With an H-index that reflects its impact, the journal holds a commendable Q2 ranking in key categories including Applied Microbiology and Biotechnology, as well as Medicine (Miscellaneous), which underscores its significance in the academic community. Despite being a subscription-based journal, the JOURNAL OF MICROBIOLOGY aims to contribute to the understanding of microbial processes and their applications, facilitating advancements that are essential in health, industry, and environmental sciences. Researchers, students, and practitioners are encouraged to explore this rich resource for the latest research and trends in microbiology.

JOURNAL OF BIOMEDICAL SCIENCE

Advancing knowledge in biomedical science for a healthier tomorrow.
Publisher: BMCISSN: 1021-7770Frequency: 1 issue/year

JOURNAL OF BIOMEDICAL SCIENCE, published by BMC, is a premier Open Access journal dedicated to the rapid dissemination of research in the fields of biomedical science, encompassing crucial areas such as biochemistry, cell biology, clinical biochemistry, and more. Since its inception in 1993, the journal has established itself as a leading publication, currently boasting a remarkable impact factor and quality as evidenced by its Q1 quartile rankings across multiple categories in 2023. With an impressive track record, including a Scopus ranking in the top percentiles across several disciplines, it serves as a vital resource for researchers, professionals, and students who are keen on advancing their knowledge in biomedicine. The journal operates under a fully Open Access model, ensuring that all published articles are freely available to the global research community, thus contributing to the broader dissemination and accessibility of scientific knowledge. Based in the United Kingdom, JOURNAL OF BIOMEDICAL SCIENCE is committed to fostering innovation and collaboration in research, appealing to those aiming to make impactful contributions to the biomedical sphere.

JOURNAL OF BASIC MICROBIOLOGY

Exploring Innovations in Applied Microbiology
Publisher: WILEYISSN: 0233-111XFrequency: 12 issues/year

JOURNAL OF BASIC MICROBIOLOGY is a premier publication in the field of microbiology, published by WILEY since 1985. With a significant presence in Germany, this journal encompasses a wide spectrum of research topics, focusing on applied microbiology and biotechnology as well as diverse areas within medicine. Holding a commendable Q2 ranking in both its categories for 2023, it plays a crucial role in disseminating innovative findings and methodologies to the community. Researchers will find it to be an essential platform for sharing high-quality work, where it currently stands at rank #47 in the applied microbiology and biotechnology category, representing the 63rd percentile among international journals. The JOURNAL OF BASIC MICROBIOLOGY caters to a growing audience of professionals and students, offering insights essential for advancement in microbiological research and its applications. While it does not currently offer an Open Access option, it remains an influential outlet for academic excellence, continuously contributing to the development of the field through its rigorous peer-reviewed articles.

ACS Infectious Diseases

Shaping the Future of Infectious Disease Research
Publisher: AMER CHEMICAL SOCISSN: 2373-8227Frequency: 12 issues/year

ACS Infectious Diseases is a premier journal in the field of infectious diseases, published by the American Chemical Society. With an impressive Impact Factor that places it in the Q1 category for Infectious Diseases in 2023, the journal serves as an essential resource for researchers, healthcare professionals, and students dedicated to the study of infectious agents and their impact on public health. Established in 2015, the journal is committed to publishing cutting-edge research that enhances our understanding of infectious diseases and fosters the development of innovative interventions. Although not an open access journal, it provides a platform for high-quality research that influences policies and practices in the field. With an address located at 1155 16TH ST, NW, WASHINGTON, DC 20036, ACS Infectious Diseases is an authoritative voice in advancing the science and practice of infectious disease management.